Gene · 2798
Papers2,995
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
161 to 180 of 2,995
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Dual trigger for final oocyte maturation in expected normal responders with a high immature oocyte rate: a randomized controlled trial. | Front Med (Lausanne) | 2023 | 37869157 | PubTator, text mining | PubMed |
| Integrative proteomic and phosphoproteomic analysis in the female goat hypothalamus to study the onset of puberty. | BMC Genomics | 2023 | 37853328 | PubTator, text mining | PubMed |
| Unexpected gender differences in progressive supranuclear palsy reveal efficacy for davunetide in women. | Transl Psychiatry | 2023 | 37845254 | PubTator, text mining | PubMed |
| The Boosting Effects of Melatonin on the In Vitro Fertilization (IVF) of Women with Polycystic Ovary Syndrome. | Chonnam Med J | 2023 | 37840679 | PubTator, text mining | PubMed |
| Relugolix vs. Leuprolide Effects on Castration Resistance-Free Survival from the Phase 3 HERO Study in Men with Advanced Prostate Cancer. | Cancers (Basel) | 2023 | 37835548 | PubTator, text mining | PubMed |
| Impact of Relugolix Versus Leuprolide on the Quality of Life of Men with Advanced Prostate Cancer: Results from the Phase 3 HERO Study. | Eur Urol | 2023 | 37833178 | PubTator, text mining | PubMed |
| Influence of Humoral Response Against GnRH, Generated by Immunization with a Therapeutic Vaccine Candidate on the Evolution of Patients with Castration-Sensitive Prostate Adenocarcinoma. | Technol Cancer Res Treat | 2023 | 37828833 | PubTator, text mining | PubMed |
| AXL receptor tyrosine kinase modulates gonadotropin-releasing hormone receptor signaling. | Cell Commun Signal | 2023 | 37828510 | PubTator, text mining | PubMed |
| Single-cell sequencing technology applied to epigenetics for the study of tumor heterogeneity. | Clin Epigenetics | 2023 | 37821906 | PubTator, text mining | PubMed |
| Clinical and molecular features of 40 Chinese patients with idiopathic hypogonadotropic hypogonadism. | Transl Androl Urol | 2023 | 37814704 | PubTator, text mining | PubMed |
| Bibliometric analysis of scientific publications on cryptorchidism: Research hotspots and trends between 2000 and 2022. | Heliyon | 2023 | 37809395 | PubTator, text mining | PubMed |
| Clinical Manifestations, Genetic Variants and Therapeutic Evaluation in Sporadic Chinese Patients with Idiopathic Hypogonadotropic Hypogonadism. | Int J Gen Med | 2023 | 37799300 | PubTator, text mining | PubMed |
| Idiopathic hypogonadotropic hypogonadism caused by compound heterozygosity for two novel mutations in the GNRH1 gene: a case report. | BMC Endocr Disord | 2023 | 37798680 | PubTator, text mining | PubMed |
| The roles of FLOT1 in human diseases (Review). | Mol Med Rep | 2023 | 37772385 | PubTator, text mining | PubMed |
| Dual trigger and the impact on oocyte quality and embryo development: a Brazilian cohort. | JBRA Assist Reprod | 2023 | 37768818 | PubTator, text mining | PubMed |
Study Protocol of a Prospective, Monocentric, Single-Arm Study Investigating the Safety and Efficacy of Local Ablation of Symptomatic Uterine Fibroids with US-Guided High-Intensity Focused Ultrasound (HIFU). | J Clin Med | 2023 | 37762868 | PubTator, text mining | PubMed |
| Inhibition of HSP90 in Driver Oncogene-Defined Lung Adenocarcinoma Cell Lines: Key Proteins Underpinning Therapeutic Efficacy. | Int J Mol Sci | 2023 | 37762133 | PubTator, text mining | PubMed |
| Cancer Therapy-Related Cardiac Dysfunction in Patients With Prostate Cancer Undergoing Androgen Deprivation Therapy. | J Am Heart Assoc | 2023 | 37750600 | PubTator, text mining | PubMed |
| Pretreatment with a long-acting GnRH agonist for frozen-thawed embryo transfer cycles: how to improve live birth? | J Ovarian Res | 2023 | 37743479 | PubTator, text mining | PubMed |
| CRISPR/Cas9-mediated activation of NR5A1 steers female human embryonic stem cell-derived bipotential gonadal-like cells towards a steroidogenic cell fate. | J Ovarian Res | 2023 | 37726790 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/2798/papers?page=9